James M. Inhofe sold CRSP

December 22, 2020 · STOCK Act disclosure

Senator James M. Inhofe (Republican-OK) sold CRISPR Therapeutics AG, a stock transaction, valued at $50,001 - $100,000. The trade took place on December 22, 2020 and was disclosed on December 23, 2020 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.

Type

Sell

Amount

$50,001 - $100,000

Transaction date

December 22, 2020

Disclosed

December 23, 2020

MemberJames M. Inhofe

ChamberSenate

Party / StateRepublican · OK

AssetCRISPR Therapeutics AG (CRSP)

Security typeStock

OwnerSelf

Amount range$50,001 - $100,000

Transaction dateDecember 22, 2020

Filing dateDecember 23, 2020

AmendmentNo

Asset description

CRISPR Therapeutics AG

View the original STOCK Act disclosure